148 related articles for article (PubMed ID: 15794867)
1. Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression.
Konduri K; Sahota SS; Babbage G; Tong AW; Kumar P; Newman JT; Stone MJ
Clin Lymphoma; 2005 Mar; 5(4):285-9. PubMed ID: 15794867
[TBL] [Abstract][Full Text] [Related]
2. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
3. IgM myeloma and Waldenstrom's macroglobulinemia: a distinct clinical feature, histology, immunophenotype, and chromosomal abnormality.
Chehal A; Taher A; Shamseddine A
Clin Lab Haematol; 2003 Jun; 25(3):187-90. PubMed ID: 12755797
[TBL] [Abstract][Full Text] [Related]
4. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.
Sahota SS; Forconi F; Ottensmeier CH; Stevenson FK
Semin Oncol; 2003 Apr; 30(2):136-41. PubMed ID: 12720123
[TBL] [Abstract][Full Text] [Related]
5. Clonal identities and multiple isotype transcripts in hematological diseases revealed by a single-strand conformation polymorphism analysis of the immunoglobulin heavy chain messenger signals.
Shiokawa S; Nishimura J; Uike N; Saburi Y; Suehiro T; Yamamoto K
Am J Hematol; 1999 Oct; 62(2):74-81. PubMed ID: 10509000
[TBL] [Abstract][Full Text] [Related]
6. Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.
Atrash S; Zhang Q; Papanikolaou X; Stein C; Abdallah AO; Barlogie B
J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241189
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
[TBL] [Abstract][Full Text] [Related]
8. The malignant clone in Waldenstrom's macroglobulinemia.
Kriangkum J; Taylor BJ; Mant MJ; Treon SP; Belch AR; Pilarski LM
Semin Oncol; 2003 Apr; 30(2):132-5. PubMed ID: 12720122
[TBL] [Abstract][Full Text] [Related]
9. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
Owen RG
Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
[TBL] [Abstract][Full Text] [Related]
10. IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM.
Bazarbachi AH; Avet-Loiseau H; Szalat R; Samur AA; Hunter Z; Shammas M; Corre J; Fulciniti M; Anderson KC; Parmigiani G; Treon SP; Mohty M; Munshi NC; Samur MK
Blood; 2021 Nov; 138(20):1980-1985. PubMed ID: 34792571
[TBL] [Abstract][Full Text] [Related]
11. IgM-expressing Waldenstrom's macroglobulinemia tumor cells reveal a potential for isotype switch events in vivo.
Babbage G; Townsend M; Zojer N; Mockridge IC; Garand R; Barlogie B; Shaughnessy J; Stevenson FK; Sahota SS
Leukemia; 2007 Apr; 21(4):827-30. PubMed ID: 17287856
[No Abstract] [Full Text] [Related]
12. Cell cycle analysis of Waldenstrom's macroglobulinemia.
Ocio EM; Mateo G; Vidriales B; Lopez-Berges MC; Garcia-Sanz R; Hernandez JM; Orfao A; San Miguel JF
Clin Lymphoma; 2005 Mar; 5(4):250-2. PubMed ID: 15794858
[TBL] [Abstract][Full Text] [Related]
13. Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor?
Kriangkum J; Taylor BJ; Reiman T; Belch AR; Pilarski LM
Clin Lymphoma; 2005 Mar; 5(4):217-9. PubMed ID: 15794851
[TBL] [Abstract][Full Text] [Related]
14. IgM myeloma--its distinction from Waldenström's macroglobulinemia.
Takahashi K; Yamamura F; Motoyama H
Acta Pathol Jpn; 1986 Oct; 36(10):1553-63. PubMed ID: 3099541
[TBL] [Abstract][Full Text] [Related]
15. [IgM myeloma: 6 cases and a review of the literature].
De Gramont A; Grosbois B; Michaux JL; Peny AM; Pollet JP; Smadja N; Krulik M; Debray J; Bernard JF; Monconduit M
Rev Med Interne; 1990; 11(1):13-8. PubMed ID: 2109345
[TBL] [Abstract][Full Text] [Related]
16. IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia.
Schuster SR; Rajkumar SV; Dispenzieri A; Morice W; Aspitia AM; Ansell S; Kyle R; Mikhael J
Am J Hematol; 2010 Nov; 85(11):853-5. PubMed ID: 20842638
[TBL] [Abstract][Full Text] [Related]
17. [Immunoglobulin levels in the serum of patients with myeloma and Waldenström's macroglobulinemia].
Linz R; Lecocq E
C R Seances Soc Biol Fil; 1971; 165(5):1191-4. PubMed ID: 4261510
[No Abstract] [Full Text] [Related]
18. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
19. Sequence and expression analyses of mu and delta transcripts in patients with Waldenström's macroglobulinemia.
Shiokawa S; Suehiro Y; Uike N; Muta K; Nishimura J
Am J Hematol; 2001 Nov; 68(3):139-43. PubMed ID: 11754393
[TBL] [Abstract][Full Text] [Related]
20. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants.
Avet-Loiseau H; Garand R; Lodé L; Harousseau JL; Bataille R;
Blood; 2003 Feb; 101(4):1570-1. PubMed ID: 12393502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]